– UK, Glasgow – DeepMatter Group PLC (LON: DMTR), the AIM-quoted company focusing on digitizing chemistry, today announced the appointment of Mirko Walter to its Board as Non-Executive Director with immediate effect, succeeding Bettina Goerner, who has stepped down from her operational role at Springer Nature, and therefore will step down from the DeepMatter Board effective today.
“I am delighted to welcome Mirko to the Board. Mirko’s passion for working with customers to create innovation based on trusted information and leading data products coupled with his wealth of experience in sales and the scientific sector will resonate with DeepMatter’s long-term strategic goal to commercialise the digitisation of chemistry. We look forward to working with Mirko as we scale up the business and enter new territories.” said CEO, Mark Warne.
He added: “We are grateful for the contribution Bettina made in the two years since the InfoChem acquisition and wish her all the very best for the future.”
Bettina joined the DeepMatter Board in March 2019, as part of the acquisition of InfoChem from Springer Nature.
The Board thanks Bettina for her contribution to DeepMatter and oversight of the successful integration of the InfoChem business into the Group and wishes her all the very best for the future.
About Mirko Walter
Mirko is currently VP, Sales of Springer Nature, the global academic publishing company, and has been with the business for six years, supporting the growth strategy through sales excellence, partnerships, and portfolio expansion. In addition to his achievements in implementing and executing sales strategies, Mirko has 18 years’ experience working with customers to optimize their Research & Development processes and investments.
Before joining Springer Nature, he was Head of Business Development at digital healthcare provider DocMorris, whilst it was part of McKesson Corporation, a leading company in the healthcare sector.
About DeepMatter Group plc
DeepMatter’s long-term strategy is to integrate chemistry with technology, thereby enabling greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesized through robotics. It has developed and is commercializing data-rich platform technologies, including software and laboratory hardware, focused on applications to improve R&D productivity and discovery using Machine Learning / Artificial Intelligence.
DeepMatter’s technologies allow chemistry experiments to be accurately and systematically recorded, coded, and entered into a shared data cloud. They are designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so discoveries may be made faster.
For more information: https://www.deepmatter.io/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
